natgillin/translations-raw huggingface dataset:
It is advised to check regularly that the queen is present, but avoid disturbing the hives in the days following treatment. 
Savjetuje se redovito provjeravati prisutnost matice, no i izbjegavati ometanje košnica nekoliko dana nakon primjene proizvoda.
MANUFACTURER'S BATCH NUMBER Batch {number} 
BROJ PROIZVODNE SERIJE Lot {broj}
Treatment should be conducted at the start of the season with increasing colony population and when the natural mite fall is more than 1 mite per day 
Tretman je potrebno provesti na početku sezone kada se povećava populacija kolonije i kada je prirodni pad grinja veći od 1 grinje na dan.
Each single dose sachet contains: 
Svaka jednodozna vrećica sadrži:
In order to establish the Varroa infestation level in a hive, the mite mortality must be monitored: mite fall should be recorded on the hive floorboard before the first treatment, and up to 6 days after each treatment. 
Potrebno je pratiti smrtnost grinja kako bi se utvrdila razina infestacije varoom u košnici: treba voditi evidenciju o padu grinja na podnici košnice prije prvog tretmana te do najviše 6 dana nakon svakog tretmana.
Honey bees 
Medonosne pčele
15 to 30 ml 
15 do 30 ml
Do not use during nectar flow. 
Ne primjenjivati tijekom cvjetne paše.
To be trickled onto bees in occupied bee-spaces of the brood chamber. 
Nakapati na pčele u zauzetim prostorima plodišta za pčele.
30 to 45 ml 
30 do 45 ml
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION In-hive use. 
DOZIRANJE ZA SVAKU CILJNU VRSTU ŽIVOTINJA, NAČIN I PUT(EVI)
Increased mortality in worker bees was very commonly observed in the clinical and preclinical trials following treatment with Varromed. 
U kliničkim i nekliničkim ispitivanjima vrlo često je opažena povećana smrtnost pčela radilica nakon tretmana VarroMedom.
Antiinfectious agents 
Tvari protiv infekcije
PACKAGE SIZE 12 x 15 ml 
12 x 15 ml
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 colonies treated displaying adverse reaction(s)) - common (more than 1 but less than 10 colonies in 100 colonies treated) - uncommon (more than 1 but less than 10 colonies in 1,000 colonies treated) - rare (more than 1 but less than 10 colonies in 10,000 colonies treated) - very rare (less than 1 colonies in 10,000 colonies treated, including isolated reports). 
- rijetke (više od 1 ali manje od 10 kolonija na 10 000 tretiranih kolonija) - vrlo rijetke (manje od 1 kolonije na 10 000 tretiranih kolonija, uključujući izolirane slučajeve).
The use of VarroMed with the above dosing scheme only applies for hives with vertical frames that can be accessed from the top, as the treatment of bees in other types of hives has not been investigated. 
Primjena VarroMeda na osnovi prethodno navedenog režima doziranja primjenjiva je samo za košnice s okomitim okvirima, kojima se može pristupiti odozgo jer tretiranje pčela u drugim vrstama košnica nije ispitano.
Season 
Proljeće
4.7 Use during pregnancy, lactation or lay 
Primjena tijekom graviditeta, laktacije ili nesenja Nije primjenjivo.
The treatment should be repeated twice, 6 days apart (i.e. 3 administrations). 
Tretman je potrebno dvaput ponoviti u razmaku od 6 dana (tj. potrebne su 3 primjene).
Formic acid /oxalic acid dihydrate 
Mravlja kiselina / dihidrat oksalne kiseline
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. 
Tiskana uputa o VMP-u mora sadržavati naziv i adresu proizvođača odgovornog za puštanje odnosne serije u promet.
Do not use this veterinary medicinal product after the expiry date, which is stated on the bottle after “EXP”. 
Ne koristite veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na boci poslije
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY 
13. POSEBNE MJERE OPREZA PRI ODLAGANJU NEUPOTREBLJENIH PROIZVODA ILI OTPADNIH MATERIJALA, AKO IH IMA
Treatment should be conducted at the start of the broodless period in hives with Varroa infestation 
Tretman je potrebno provesti na početku razdoblja bez legla u košnicama infestiranima varoom.
INDICATION(S) Treatment of varroosis (Varroa destructor) in honey bee colonies with and without brood. 
INDIKACIJA(E) Liječenje varooze (Varroa destructor) u kolonijama medonosnih pčela, s leglom i bez legla.
Oxalic acid dihydrate 
Dihidrat oksalne kiseline
6.5 Nature and composition of immediate packaging 
Osobine i sastav unutarnjeg pakovanja
Marketing authorisation holder : 
Nositelj odobrenja za stavljanje u promet:
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products 
Posebne mjere opreza prilikom odlaganja neupotrebljenog veterinarsko-medicinskog proizvoda ili otpadnih materijala dobivenih primjenom tih proizvoda
Shelf life after first opening the container: 30 days 
Rok valjanosti nakon prvog otvaranja spremnika: 30 dana.
6.5 Nature and composition of immediate packaging Cardboard box containing an HDPE bottle with dropper nozzle (LDPE) and screw cap (with tamper evident seal). 
Kartonska kutija sadrži bocu od polietilena visoke gustoće (HDPE), s mlaznicom s kapaljkom od polietilena niske gustoće (LDPE) i zatvaračem na navoj (sa sigurnosnim zatvaračem protiv otvaranja).
Each ml contains: 
Svaka vrećica sadrži:
5.2 Pharmacokinetic particulars 
5.3. Farmakodinamička svojstva
Repeated administration of VarroMed might be required for spring or autumn treatment at intervals of 6 days, repeated applications should only be performed as indicated by mite-fall in accordance with the following table: 
Za tretmane u proljeće ili jesen možda će biti potrebna ponovljena primjena u vremenskim razmacima od 6 dana, pri čemu ponavljane primjene treba provoditi samo prema padu grinja sukladno sljedećoj tablici:
PACKAGE LEAFLET: VarroMed bee-hive dispersion for honey bees 
VarroMed, disperzija za košnice za medonosne pčele
NAME OF THE VETERINARY MEDICINAL PRODUCT VarroMed bee-hive dispersion for honey bees Formic acid / oxalic acid dihydrate 
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA VarroMed, disperzija za košnice Mravlja kiselina / dihidrat oksalne kiseline
METHOD AND ROUTE(S) OF ADMINISTRATION In-hive use. 
NAČIN I PUT(EVI) PRIMJENE
STATEMENT OF ACTIVE SUBSTANCES Each sachet contains: 
KVALITATIVNI I KVANTITATIVNI SASTAV Djelatne tvari:Svaki ml sadrži:
Shelf life after first opening the immediate packaging: 30 days. 
Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: 30 dana.
660 mg (equivalent to 471.31 mg oxalic acid) 
660 mg (istovjetno 471,31 mg oksalne kiseline)
The use of VarroMed with the above dosing scheme only applies for hive types with vertical frames that can be accessed from the top, as the treatment of bees in other types of hives has not been investigated. 
45 ml Primjena VarroMeda na osnovi prethodno navedenog režima doziranja primjenjiva je samo za košnice s okomitim okvirima, kojima se može pristupiti odozgo jer tretiranje pčela u drugim vrstama košnica nije ispitano.
Repeated administration of VarroMed might be required for spring or autumn treatment at intervals of 6 days; repeated applications should only be performed as indicated by mite-fall in according with the following table: 
Za tretmane u proljeće ili jesen možda će biti potrebna ponovljena primjena u vremenskim razmacima od 6 dana, pri čemu ponavljane primjene treba provoditi samo prema padu grinja sukladno sljedećoj tablici: Sezona
NAME OF THE VETERINARY MEDICINAL PRODUCT VarroMed 75 mg + 660 mg bee-hive dispersion Formic acid/oxalic acid dihydrate 
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA VarroMed 75 mg + 660 mg, disperzija za košnice Mravlja kiselina/dihidrat oksalne kiseline
PACKAGE SIZE 555 ml 
555 ml
44 mg (equivalent to 31.42 mg oxalic acid) 
44 mg (istovjetno 31,42 mg oksalne kiseline)
NAME OF THE VETERINARY MEDICINAL PRODUCT VarroMed 5 mg/ml + 44 mg/ml bee-hive dispersion Formic acid/oxalic acid dihydrate 
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA VarroMed 5 mg/ml + 44 mg/ml, disperzija za košnice Mravlja kiselina/dihidrat oksalne kiseline
PHARMACEUTICAL FORM Bee-hive dispersion. 
OBLIK Disperzija za košnice.
Treatment of varroosis (Varroa destructor) in honey bee colonies with and without brood. 
Liječenje varooze (Varroa destructor) u kolonijama medonosnih pčela s leglom i bez legla.
Oxalic acid 
Oksalna kiselina
QUANTITY OF THE ACTIVE SUBSTANCE(S) Formic acid 
Djelatne tvari: Svaki ml sadrži: Mravlja kiselina
Honey: Zero days. 
grinje na dan.
No data are available which confirm this activity after trickling of 0.5% formic acid; however, formic acid in the fixed combination of VarroMed is considered to extend the duration of the effect of oxalic acid, and to improve the tolerance of the product. 
Nisu dostupni podaci koji potvrđuju tu aktivnost nakon kapanja 0,5 % mravlje kiseline.
4.9 Amounts to be administered and administration route In-hive use. 
Količine koje se primjenjuju i put primjene Primjena u košnici.
Formic acid 
Mravlja kiselina
During the application of the veterinary medicinal product, wear protective clothing, acid-resistant gloves and glasses. 
Nosite zaštitnu odjeću, rukavice otporne na kiseline i zaštitne naočale tijekom primjene ovog veterinarsko-medicinskog proizvoda.
PHARMACEUTICAL FORM Bee-hive dispersion 
OBLIK Disperzija za košnice
up to 5x possible in late summer/early autumn with decreasing colony population, and when the natural mite fall is more than 4 mites per day. 
Tretman je potrebno što prije provesti u kasno ljeto/ranu jesen kada se smanjuje populacija kolonije i kada je prirodni pad grinja veći od 4 grinje na dan.
None known. 
NEMA UNOSA
NAME OF THE VETERINARY MEDICINAL PRODUCT VarroMed 5 mg/ml + 44 mg/ml bee-hive dispersion for honey bees 
VarroMed 5 mg/ml + 44 mg/ml, disperzija za košnice za medonosne pčele
NAME OF THE VETERINARY MEDICINAL PRODUCT VarroMed 75 mg + 660 mg bee-hive dispersion for honey bees 
VarroMed 75 mg + 660 mg, disperzija za košnice za medonosne pčele
WITHDRAWAL PERIOD(S) Honey: Zero days. 
KARENCIJA(E) Med: nula dana.
ANNEX III LABELLING AND PACKAGE LEAFLET 
OZNAČAVANJE I UPUTA O VMP-u
decreasing colony population, and when the natural mite fall is more than 4 mites per day. 
5x jesen kada se smanjuje populacija kolonije i kada je prirodni pad grinja veći od 4
MARKETING AUTHORISATION NUMBER(S) EU/2/16/203/002 
BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET EU/2/16/203/002
Spring 
NUSPOJAVE
Shelf life of the veterinary medicinal product as packaged for sale: 2 years Shelf life after first opening the immediate packaging: use immediately. 
Rok valjanosti poslije prvog otvaranja unutarnjeg pakovanja: smjesta upotrijebiti.
MARKETING AUTHORISATION NUMBER(S) EU/2/16/203/001 
BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET EU/2/16/203/001
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS 15 ml Sachet 
OSNOVNI PODACI KOJI SE MORAJU NALAZITI NA MALIM UNUTARNJIM PAKOVANJIMA
Dose: 
Inkompatibilnosti:
WITHDRAWAL PERIOD(S) Withdrawal period(s): Honey: Zero days. 
KARENCIJA(E) Karencija(e): med: nula dana.
The treatment should be repeated twice, 6 days apart (i.e. 3 
Tretman je potrebno dvaput ponoviti u razmaku od 6 dana
administrations). 
NJEMAČKA
MARKETING AUTHORISATION NUMBER(S) EU/2/16/203/002 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 02/02/2017 
Datum prvog odobrenja: 02/02/2017
Frequency of treatment: 
Učestalost tretmana:
TARGET SPECIES Honey bees. 
Medonosne pčele.
N/A Bees 
Pčele
WITHDRAWAL PERIOD(S) Withdrawal period(s) (honey): zero days. 
KARENCIJA(E) Karencija(e) (med): nula dana.
BeeVital GmbH Wiesenbergstr. 
NOSITELJ ODOBRENJA ZA STAVLJANJE U PROMET BeeVital GmbH
STATEMENT OF ACTIVE SUBSTANCES Active substances: 
SASTAV DJELATNIH TVARI Djelatne tvari:
No of applications 
Broj primjena
ROUTE(S) OF ADMINISTRATION In-hive use. 
PUT(EVI) PRIMJENE Primjena u košnici.
In very rare cases (<1/100,000), hypersensitivity can be observed. 
U vrlo rijetkim slučajevima (< 1/100 000) može se pojaviti preosjetljivost.
Wash and disinfect hands and equipment after use. 
Oprati i dezinficirati ruke i opremu nakon primjene.
One dose of 2 ml contains: 
Jedna doza od 2 ml sadrži:
Mineral oil (Marcol 52) 
Mineralno ulje (Marcol 52)
Do not mix with any other vaccine or immunological product. 
Ne miješati s bilo kojim drugim cjepivom ili imunološkim proizvodom.
b) the disease to which the product is intended to confer immunity is largely absent from the territory in question. 
b) je bolest, za koju je proizvod namijenjen da pruži imunost, u velikoj mjeri odsutna s odnosnog područja.>
Use sterile syringes and needles. 
Upotrebljavajte sterilne štrcaljke i igle.
CONTENTS BY WEIGHT, BY VOLUME OR NUMBER OF DOSES 10 doses 
SADRŽAJ PO TEŽINI, VOLUMENU ILI BROJU DOZA
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary Apart from an increase in the extent of the tissue reaction at the site of injection, no other undesirable effects have been observed. 
4.10 Predoziranje (simptomi, hitni postupci, antidoti), ako je nužno Osim povećanja opsega reakcije tkiva na mjestu injiciranja, nisu uočene nikakve druge nuspojave.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/). 
Detaljne informacije o ovom veterinarsko-medicinskom proizvodu su dostupne na web stranici European Medicines Agency http://www.ema.europa.eu/.
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE 
13. RIJEČI „SAMO ZA PRIMJENU NA ŽIVOTINJAMA“ I UVJETI ILI OGRANIČENJA U POGLEDU OPSKRBE I PRIMJENE, ako je primjenjivo
A second dose may be injected 3-4 weeks after the first injection. 
Druga doza može se injicirati 3 - 4 tjedna nakon prve injekcije.
Zoetis B.V., Podružnica Zagreb za promidžbu 
Hrvatska Zoetis B.V., Podružnica Zagreb za promidžbu
Each piglet of vaccinated gilts or sows should ingest a sufficient quantity of colostrum and milk. 
Svaki praščić cijepljenih nazimica ili krmača trebao bi unijeti dovoljnu količinu kolostruma i mlijeka.
QUALITATIVE AND QUANTITATIVE COMPOSITION Powder: 
KVALITATIVNI I KVANTITATIVNI SASTAV Prašak:
Special precautions to be taken by the person administering the veterinary medicinal product to animals 
Posebne mjere opreza koje mora poduzeti osoba koja primjenjuje veterinarsko medicinski proizvod na životinjama
Mannide mono oleate (Arlacel A) 
Manid monooleat (Arlacel A)
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 07/08/1998 
Datum prvog odobrenja: 07/08/1998 Datum posljednjeg produljenja odobrenja: 22/08/2008
Do not use this veterinary medicinal product after the expiry date which is stated on the label. 
Ne koristite veterinarsko-medicinski proizvod poslije roka valjanosti naznačenog na etiketi poslije EXP.
• Inject one dose per gilt before the first mating, or 
• Injicirati jednu dozu po nazimici prije prvog parenja ili
According to Article 71 of Directive 2001/82/EC of the European Parliament and of the Council as amended, a Member State may, in accordance with its national legislation, prohibit the manufacture, import, possession, sale, supply and/or use of immunological veterinary medicinal products on the whole or part of its territory if it is established that: 
Sukladno članku 71. Direktive 2001/82/EK i Europskog Parlamenta i Vijeća s izmjenama i dopunama, države članice, u skladu s nacionalnim zakonodavstvom mogu zabraniti proizvodnju, uvoz, posjedovanje, prodaju, opskrbu i/ili primjenu imunoloških veterinarsko-medicinskih proizvoda na cijelom ili na dijelu svog teritorija ako je utvrđeno da:
Polysorbate 80 (Tween 80) 
Polisorbat 80 (Tween 80)
Shelf-life after reconstitution according to directions: 1 hour. 
Rok valjanosti nakon rekonstitucije prema uputama: 1 sat.
• Inject one dose per gilt or sow during each gestation at 3-6 weeks before the expected date of farrowing. 
• Injicirati jednu dozu po nazimici ili krmači tijekom svake gestacije 3 - 6 tjedana prije očekivanog datuma prasenja.
• Inject one dose per boar at least every 6 months. 
• Injicirati jednu dozu po nerastu barem svakih 6 mjeseci.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton label 1 x 10 doses, 1 x 50 doses, 1 x 100 doses, 10 x 10 doses, 10 x 50 doses, 10 x 100 doses 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Etiketa na kutiji 1 x 10 doza, 1 x 50 doza, 1 x 100 doza, 10 x 10 doza, 10 x 50 doza, 10 x 100 doza
Apart from an increase in the extent of the tissue reaction at the site of injection, no other undesirable effects have been observed. 
Osim povećanja opsega reakcije tkiva na mjestu injiciranja, nisu uočene nikakve druge nuspojave.
Administer by intramuscular injection of 1 dose (2 ml) per pig in the neck in the area behind the ear. 
Primijenite intramuskularnom injekcijom 1 doze (2 ml) po svinji u vrat u području iza uha.
For whole herd vaccination, an injection of one dose may be administered per gilt, sow and boar every 4 months. 
Za cijepljenje čitavog stada treba primijeniti injekciju od jedne doze po svakoj nazimici, krmači i nerastu svaka 4 mjeseca.
The presence of maternal antibodies against Aujeszky's disease virus may have a negative influence on the result of vaccination. 
Prisutnost majčinih protutijela protiv virusa bolesti Aujeszkoga može imati negativan utjecaj na rezultat cijepljenja.
* CCID50 - the quantity of virus, which infects 50 % of the cell cultures inoculated. 
* CCID50 = količina virusa, koja inficira 50% inokuliranih staničnih kultura.
Therefore, the product is suitable to be used in eradication programmes against Aujeszky's disease field virus in pigs based on the presence or absence of antibodies against the gE-antigen of that virus. 
Stoga je proizvod pogodan za primjenu u programima iskorjenjivanja terenskog virusa bolesti Aujeszkoga kod svinja na temelju prisutnosti ili odsutnosti protutijela protiv gE-antigena tog virusa.
Slight, transient and local reactions up to 2 cm in diameter after first vaccination and up to 5 cm after second vaccination may occur up to 50 % of the pigs. 
Blage, prolazne i lokalne reakcije do 2 cm u promjeru nakon prvog cijepljenja i do 5 cm nakon drugog cijepljenja mogu se pojaviti u do 50% svinja.
Vaccination programme: 
Program cijepljenja:
A transient increase in body temperature, up to about 40,5 oC and lasting for up to 2 days, may occur in a small number of pigs after vaccination. 
Prolazno povišenje tjelesne temperature, do približno 40,5°C u trajanju do 2 dana, može se pojaviti u malog broja svinja nakon cijepljenja.
Camprodón s/n "la Riba" 17813 Vall de Bianya 
Camprodón s/n "la Riba" 17813 Vall de Bianya Girona
The bottles are closed with a butyl rubber stopper and sealed with an aluminium cap. 
Bočice su zatvorene čepom od butilne gume i zapečaćene aluminijskom kapicom.
To reconstitute the vaccine, inject 3 ml of solvent into the small vial with the powder. 
Da biste rekonstituirali cjepivo, ubrizgajte 3 ml otapala u malu bočicu s praškom.
Any person intending to manufacture, import, possess, sell, supply and use Suvaxyn Aujeszky 783 + O/W must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession, sale, supply and/or use. 
Tko namjerava proizvoditi, uvesti, posjedovati, prodavati, opskrbljivati i/ili primjenjivati Suvaxyn Aujeszky 783 + O/W mora se savjetovati s nadležnim tijelom odnosne države članice u pogledu važećih odredbi o cijepljenju prije proizvodnje, uvoza, posjedovanja, prodaje, opskrbe i/ili primjene.
Shelf life after reconstitution: Use within one hour. 
EXP {mjesec/godina} Rok valjanosti poslije rekonstitucije: potrošiti u roku od sat vremena
Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities. 
Zbrinite otpadni materijal prokuhavanjem, spaljivanjem ili uranjanjem u prikladno dezinfekcijsko sredstvo koje je nadležno tijelo odobrilo za upotrebu.
The gE- (glycoprotein E negative) characteristic of the vaccine virus makes it possible to distinguish between antibodies induced by vaccination with this product and those induced by field infection with Aujeszky's disease virus, if the vaccine is used in association with an appropriate diagnostic test. 
Karakteristika virusa cjepiva gE- (glikoprotein E negativni) omogućuje razlikovanje protutijela induciranih cijepljenjem ovim proizvodom i protutijela induciranih terenskom infekcijom virusom bolesti Aujeszkoga ako se cjepivo primjenjuje uz odgovarajući dijagnostički test.
Shelf-life of the veterinary medicinal product as packaged for sale (powder): 2 years. 
Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju (prašak): 2 godine.
SPECIAL STORAGE PRECAUTIONS Keep out of the sight and reach of children. 
11. POSEBNE MJERE PRI ČUVANJU Čuvati izvan pogleda i dosega djece.
Basic vaccination of fattening pigs and breeding pigs (gilts, sows and boars): 
Temeljno cijepljenje tovnih svinja i rasplodnih svinja (nazimica, krmača i nerasta):
• Inject one dose per fattening pig from the age of 10 weeks. 
• Injicirati jednu dozu po tovnoj svinji od 10 tjedana starosti nadalje.
One dose (2 ml) of reconstituted emulsion containing ≥ 105.2 CCID50 of live attenuated Aujeszky's disease virus strain NIA3-783 for each pig. 
Jedna doza (2 ml) rekonstituirane emulzije koja sadrži ≥ 105,2 CCID50 živog, atenuiranog virusa bolesti Aujeszkoga soja NIA3-783 za svaku svinju.
Re-vaccination of breeding pigs (gilts, sows and boars): 
Revakcinacija rasplodnih svinja (nazimica, krmača i nerasta):
- Active immunity: The onset of immunity is from 3 weeks after basic vaccination. 
- Aktivni imunitet: Imunitet se javlja od trećeg tjedna nakon primarnog cijepljenja.
MARKETING AUTHORISATION NUMBER(S) EU/2/98/009/001-006 
EU/2/98/009/001-006
The immunity lasts for 3 months after basic vaccination. 
Imunitet traje tri mjeseca nakon primarnog cijepljenja.
Progeny of vaccinated gilts and sows derive a passive immunity via the colostrum and milk. 
Potomci cijepljenih nazimica i krmača stječu pasivan imunitet putem kolostruma i mlijeka.
SPECIAL STORAGE CONDITIONS Store and transport refrigerated (2 ºC - 8 ºC). 
11. POSEBNI UVJETI ČUVANJA Čuvati i prevoziti na hladnom (2 ºC - 8 ºC).
Pharmacotherapeutic group: live Aujeszky's disease vaccine. 
IMUNOLOŠKA SVOJSTVA Farmakoterapijska grupa: Živa vakcina bolesti Aujeszkoga
MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE 
PROIZVOĐAČI BIOLOŠKI DJELATIH TVARI I PROIZVOĐAČI ODGOVORANI ZA PUŠTANJE SERIJE U PROMET
Accidental injection is dangerous - see package insert before use for further information and additional warnings. 
POSEBNA UPOZORENJA, AKO JE POTREBNO Nehotično je injiciranje opasno - vidi uputu o VMP prije primjene za daljnje informacije i dodatna upozorenja.
Aluminium hydroxide Mineral oil (Marcol 52) Mannide mono oleate (Arlacel A) Polysorbate 80 (Tween 80) Thiomersal 
Mineralno ulje (Marcol 52) Manid monooleat (Arlacel A) Polisorbat 80 (Tween 80) Tiomersal
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION 
DOZIRANJE ZA SVAKU CILJNU VRSTU ŽIVOTINJA, NAČIN I PUTOVI PRIMJENE
By reconstitution of the immunogen in the oil emulsion, the stimulation of immunity after injection is prolonged. 
Rekonstitucijom imunogena u uljnoj emulziji produljuje se stimulacija imuniteta nakon injekcije.
Shelf-life of the veterinary medicinal product as packaged for sale (solvent): 2 years. 
Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju (otapalo): 2 godine.
In general these reactions disappear within 3 weeks after the first vaccination. 
Općenito, te se reakcije povlače unutar 3 tjedna nakon prvog cijepljenja.
• Inject one dose per breeding pigs (gilts, sows and boars) from the age of 10 weeks followed by a second injection 3-4 weeks after the first injection. 
• Injicirati jednu dozu po rasplodnoj svinji (nazimice, krmače i nerasti) od 10 tjedana starosti nadalje, a 3 - 4 tjedna kasnije treba primijeniti drugu injekciju.
QUANTITY OF THE ACTIVE SUBSTANCE(S) Live attenuated Aujeszky's disease virus 
KOLIČINA DJELATNE(IH) TVARI Živi, atenuirani virus bolesti Aujeszkoga